Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III)

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 26, 2016

Study Completion Date

December 26, 2016

Conditions
Biliary NeoplasmsBiliary ObstructionPancreatic Neoplasms
Interventions
DEVICE

Paclitaxel-eluting metal Stent

Insertion of Niti-S Mira-Cover III Biliary Stent using ERCP

DEVICE

Covered Metal Stent

Insertion of ComVi Biliary Covered Stent using ERCP

Trial Locations (5)

633-165

Inje University Busan Paik Hospital, Busan

110-744

Seoul National University Hospital, Seoul

400-711

In Ha University Hospital, Incheon

130-710

Samsung Medical Center, Seoul

135-720

Gangnam Severance Hospital, Seoul

All Listed Sponsors
lead

Taewoong Medical Co., Ltd.

INDUSTRY

NCT02460432 - Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III) | Biotech Hunter | Biotech Hunter